Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth

Sabin's picture Submitted by Sabin on

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs. Elizabeth Fox, Saad Omer and Jacqueline Shea, well-respected leaders whose range of skills and experience promise to advance Sabin’s aim to ensure all people, everywhere get the vaccines they need.

GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute

Sabin's picture Submitted by Sabin on

LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus.

2019 Albert B. Sabin Gold Medal Ceremony

04.02.19
Washington, D.C.
View event +

We’ve Come a Long Way: Supplement from the 10th International Conference on Typhoid and Other Invasive Salmonelloses

03.01.19

Originally posted on Take on Typhoid.

Read more

Developing New Vaccines: Q&A with Sabin Vaccine Institute CEO Amy Finan

08.14.18

Amy Finan, chief executive officer of the Sabin Vaccine Institute, discussed Sabin’s commitment to vaccine development and the challenges of developing and bringing vaccines to market.

Why is Sabin committed to vaccine development?

Read more

Annual Letter - 2017 Annual Report

08.10.18

For 25 years, Sabin has been a trusted partner, working with countries, the World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and regional stakeholders to improve immunization.

Read more

Sabin Gold Medal Award Honors Dr. Paul Offit

04.25.18
Last night, more than one hundred guests joined together to honor Dr. Paul Offit as the recipient of the 2018 Sabin Gold Medal. Colleagues, family, friends and peers gathered at the National Academy of Sciences building in Washington, D.C., to celebrate Dr. Offit’s contributions to immunization, including his achievements as the co-inventor of an oral rotavirus vaccine and his leadership as a vocal and dedicated advocate for immunization.
Read more

Typhoid Vaccine Consortium Publishes First Meeting Report

09.11.17

New typhoid conjugate vaccines offer important advantages over prior vaccines, including the ability to protect young children, longer lasting protection, and the potential to be a part of routine immunization of infants.

Read more

G20 Leaders Issue Call to Strengthen Global Health Capacities

07.10.17

This past weekend, leaders of the world’s major economies gathered in Hamburg, Germany, for this year’s G20 Summit. Among the issues on the agenda: safeguarding against health crises and strengthening health systems.

Read more

Pages